摘要 : The COVID-19 global pandemic has influenced all of our lives to a degree that typically occurs once per century. An event of such magnitude compels us to utilize 'pre-COVID-19' and 'post-COVID-19' terminology, analogous to other m... 展开 The COVID-19 global pandemic has influenced all of our lives to a degree that typically occurs once per century. An event of such magnitude compels us to utilize 'pre-COVID-19' and 'post-COVID-19' terminology, analogous to other major global events such as the world wars of the 20th Century. In many ways, the COVID-19 global pandemic has acted like a catalyst for rapid change, and both challenged and enabled changes in our perspectives that would have been inconceivable in the pre-COVID-19 world. Within the healthcare arena, one of the most radical COVID-19-induced changes has been the adoption of remote management practices. This is particularly relevant for patients with long-term chronic conditions such as malignancies [1] and Diabetes Mellitus (DM), that require focused and regular follow-up by healthcare professionals (HCPs) within diverse settings such as out-patient clinics, primary care facilities or within the community. Given the utility of improved glycemic control in patients with DM on reducing the risk for adverse clinical outcomes from COVID-19 [2], it is important to consider the impact on patients with DM from the adoption of remote management practices post-COVID-19. We consider this from both the HCP and patient perspective. 收起